Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel
Mojca Jensterle, Rok Herman, Andrej Janež, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7326-7326
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Higher vulnerability to poor circadian light hygiene in individuals with a history of COVID-19
Denis Gubin, Yu. V. Boldyreva, Oliver Stefani, et al.
Chronobiology International (2025), pp. 1-14
Closed Access | Times Cited: 2
The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review
Taïeb Ach, Ben Haj Slama Nassim, Gorchane Asma, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 1, pp. 96-109
Open Access | Times Cited: 7
Glucocorticoids and COVID-19
Stefano Bruscoli, Pier Giorgio Puzzovio, Maria Zaimi, et al.
Pharmacological Research (2022) Vol. 185, pp. 106511-106511
Open Access | Times Cited: 27
The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy
Abdulla A.‐B. Badawy
Bioscience Reports (2023) Vol. 43, Iss. 8
Open Access | Times Cited: 19
Pituitary and SARS CoV-2: An unremitting conundrum
Cristina Căpățînă, Cătălina Poiană, Maria Fleseriu
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101752-101752
Open Access | Times Cited: 16
SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock, Nicole Toepfner, Felix Beuschlein, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101761-101761
Open Access | Times Cited: 16
Pornography and sexual function in the post-pandemic period: a narrative review from psychological, psychiatric, and sexological perspectives
Kathryn Fotinos, Andrea Sansone, A. Greifenberger, et al.
International Journal of Impotence Research (2024) Vol. 36, Iss. 7, pp. 706-714
Closed Access | Times Cited: 5
Long-COVID-19 autonomic dysfunction: An integrated view in the framework of inflammaging
Sergio Giunta, Chiara Giordani, María De Luca, et al.
Mechanisms of Ageing and Development (2024) Vol. 218, pp. 111915-111915
Closed Access | Times Cited: 5
Post-pandemic insights on COVID-19 and premature ovarian insufficiency
Yaguang Han, Yang Dai, Kexin Wang, et al.
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access
mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAIS
Jacob Bar‐Tana
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Determination of Cortisol Levels in a Small Volume of Saliva of COVID-19-Recovering Patients During Treatment with Psychotropic Drugs
Ewelina Dziurkowska, Grażyna Guz-Rzeniecka, Maciej Dziurkowski
Biomedicines (2025) Vol. 13, Iss. 3, pp. 697-697
Open Access
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 24
Role of the microbiota-gut-brain axis in postacute COVID syndrome
Mélanie G. Gareau, Kim E. Barrett
AJP Gastrointestinal and Liver Physiology (2023) Vol. 324, Iss. 4, pp. G322-G328
Open Access | Times Cited: 13
Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
Avraham Ishay, Elena Chertok Shacham
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Improving Neuropsychological Rehabilitation for COVID-19 Patients
Catherine Widmann, Juliana Kolano, Martin Peper
Zeitschrift für Neuropsychologie (2023) Vol. 34, Iss. 2, pp. 57-70
Open Access | Times Cited: 12
The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact
Nitin Kapoor, Sanjay Kalra, Wael Al Mahmeed, et al.
Diabetes Therapy (2022) Vol. 13, Iss. 10, pp. 1723-1736
Open Access | Times Cited: 18
Conceptual foundations of acetylcarnitine supplementation in neuropsychiatric long COVID syndrome: a narrative review
Dario-Lucas Helbing, Eva-Maria Dommaschk, Lena Vera Danyeli, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024) Vol. 274, Iss. 8, pp. 1829-1845
Open Access | Times Cited: 3
Hypopituitarism and COVID-19
Giulia Carosi, Arianna Cremaschi, Claudia Giavoli, et al.
Pituitary (2024)
Closed Access | Times Cited: 3
The Potential Role of Hypothalamic Phospholipid Liposomes in the Supportive Therapy of Some Manifestations of Post-COVID-19 Condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Brain Fog
Francesco Menichetti
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5478-5478
Open Access | Times Cited: 9
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel
Djordje S. Popovic, Νικόλαος Παπάνας, Theocharis Koufakis, et al.
Experimental and Clinical Endocrinology & Diabetes (2023) Vol. 131, Iss. 05, pp. 260-267
Closed Access | Times Cited: 8
The Intersections of COVID-19, HIV, and Race/Ethnicity: Machine Learning Methods to Identify and Model Risk Factors for Severe COVID-19 in a Large U.S. National Dataset
Miranda Kunz, Kollin W. Rott, Eric Hurwitz, et al.
AIDS and Behavior (2024) Vol. 28, Iss. S1, pp. 5-21
Closed Access | Times Cited: 2
Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets
Wolfgang Poller, Bettina Heidecker, Enrico Ammirati, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 335-335
Open Access | Times Cited: 6
Exploration of the Noncoding Genome for Human-Specific Therapeutic Targets—Recent Insights at Molecular and Cellular Level
Wolfgang Poller, Susmita Sahoo, Roger J. Hajjar, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2660-2660
Open Access | Times Cited: 6
Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study
Sana Asif, Robert Frithiof, Anders Larsson, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 164-164
Open Access | Times Cited: 5
Hypothalamic-Pituitary Axis Function and Adrenal Insufficiency in COVID-19 Patients
Emre Durcan, Ayşa Hacıoğlu, Züleyha Karaca, et al.
NeuroImmunoModulation (2023) Vol. 30, Iss. 1, pp. 215-225
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top